US 7235534
Antisense strategy to modulate estrogen receptor response (ER α and/or ER β )
granted A61KA61K38/00A61K39/00
Quick answer
US patent 7235534 (Antisense strategy to modulate estrogen receptor response (ER α and/or ER β )) held by INSTITUT DE CARDIOLOGIE DE MONTREAL expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CARDIOLOGIE DE MONTREAL
- Grant date
- Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61K39/00, A61P, A61P9/00